Esperion Therapeutics (ESPR) Shares Outstanding: 2018-2025
Historic Shares Outstanding for Esperion Therapeutics (ESPR) over the last 7 years, with Sep 2025 value amounting to $205.4 million.
- Esperion Therapeutics' Shares Outstanding rose 5.11% to $205.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $205.4 million, marking a year-over-year increase of 5.11%. This contributed to the annual value of $195.9 million for FY2024, which is 65.68% up from last year.
- As of Q3 2025, Esperion Therapeutics' Shares Outstanding stood at $205.4 million, which was up 2.64% from $200.2 million recorded in Q2 2025.
- In the past 5 years, Esperion Therapeutics' Shares Outstanding registered a high of $205.4 million during Q3 2025, and its lowest value of $26.2 million during Q1 2021.
- Moreover, its 3-year median value for Shares Outstanding was $194.6 million (2024), whereas its average is $163.1 million.
- Its Shares Outstanding has fluctuated over the past 5 years, first decreased by 5.32% in 2021, then skyrocketed by 167.70% in 2022.
- Over the past 5 years, Esperion Therapeutics' Shares Outstanding (Quarterly) stood at $60.9 million in 2021, then increased by 22.49% to $74.6 million in 2022, then surged by 58.52% to $118.2 million in 2023, then soared by 65.68% to $195.9 million in 2024, then grew by 5.11% to $205.4 million in 2025.
- Its last three reported values are $205.4 million in Q3 2025, $200.2 million for Q2 2025, and $196.7 million during Q1 2025.